Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-23

FDA Approved: TOLTERODINE TARTRATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's original application for Tolterodine Tartrate, a generic treatment for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolterodine tartrate (Tolterodine tartrate)

Snippet

ORIG AP for TOLTERODINE TARTRATE (TOLTERODINE TARTRATE)